Institutional Ownership
Edwards Lifesciences Corp
CUSIP 28176E108COMEWQ1 2026
13D / 13G Filings
15
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
11.7%
Max % of class reported
Institutional Holders
1,278
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
15 filings · latest Oct 17, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 7.5% | 44.27M | SEC |
| 2 | Aug 12, 2025 | Wellington Management Group LLP | 13G/A | 3.4% | 19.83M | SEC |
| 3 | Jan 30, 2025 | The Vanguard Group | 13G/A | 11.7% | 69.13M | SEC |
| 4 | Nov 8, 2024 | Wellington Management Group LLP | 13G | 5.2% | 31.53M | SEC |
| 5 | Oct 4, 2024 | Vanguard Group Inc | 13G/A | 10.4% | 62.59M | SEC |
| 6 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 8.6% | 52.36M | SEC |
| 7 | Jan 25, 2024 | Blackrock Inc. | 13G/A | 8.6% | 52.17M | SEC |
| 8 | Feb 9, 2023 | Vanguard Group Inc | 13G/A | 8.3% | 51.56M | SEC |
| 9 | Feb 7, 2023 | Blackrock Inc. | 13G/A | 8.6% | 53.06M | SEC |
| 10 | Feb 9, 2022 | Vanguard Group Inc | 13G/A | 7.9% | 49.08M | SEC |
5 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Edwards Lifesciences Corp.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 52.59M | $4.21B |
| 2 | Vanguard Capital Management LLC | 37.73M | $3.02B |
| 3 | Vanguard Portfolio Management LLC | 26.41M | $2.11B |
| 4 | State Street Corp | 26.30M | $2.11B |
| 5 | Wellington Management Group LLP | 22.01M | $1.76B |
| 6 | Jpmorgan Chase & Co | 21.74M | $1.73B |
| 7 | Bank Of New York Mellon Corp | 16.74M | $1.34B |
| 8 | Fmr LLC | 14.50M | $1.16B |
| 9 | Geode Capital Management, LLC | 13.13M | $1.05B |
| 10 | Jennison Associates LLC | 13.07M | $1.05B |